Profile data is unavailable for this security.
About the company
Waters Corporation offers analytical instruments and software across chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, food, and environmental sciences. The Company primarily designs, manufactures, sells and services high-performance liquid chromatography (HPLC), ultra-performance liquid chromatography and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and comprehensive post-warranty service plans. Its segments include Waters and TA. The Waters segment is primarily in the business of designing, manufacturing, selling and servicing liquid chromatography (LC) and MS instrument systems, columns and other precision chemistry consumables that can be integrated and used along with other analytical instruments. The TA segment is primarily in the business of designing, manufacturing, selling and servicing thermal analysis, rheometry and calorimetry instruments.
- Revenue in USD (TTM)2.91bn
- Net income in USD622.64m
- Incorporated1991
- Employees7.90k
- LocationWaters Corp34 MAPLE STMILFORD 01757-3604United StatesUSA
- Phone+1 (508) 478-2000
- Fax+1 (508) 872-1990
- Websitehttps://www.waters.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Globus Medical Inc | 2.48bn | 91.51m | 13.44bn | 5.00k | 127.66 | 2.83 | 38.41 | 5.42 | 0.6636 | 0.6636 | 18.08 | 29.94 | 0.4747 | 1.28 | 4.58 | 495,719.20 | 1.75 | 6.90 | 1.99 | 7.45 | 58.14 | 71.73 | 3.69 | 14.05 | 1.64 | -- | 0.0974 | 0.00 | 53.34 | 17.08 | -35.39 | -4.72 | 5.57 | -- |
| Revvity Inc | 2.72bn | 258.26m | 13.63bn | 11.50k | 53.48 | 1.73 | 19.86 | 5.01 | 2.09 | 2.06 | 22.06 | 64.88 | 0.2078 | 2.89 | 4.37 | 236,657.00 | 1.97 | 4.76 | 2.15 | 5.39 | 55.44 | 57.19 | 9.49 | 15.34 | 2.97 | 11.96 | 0.2869 | 6.52 | -16.95 | -0.1982 | -64.99 | -5.28 | -2.69 | 0.00 |
| Avantor Inc | 6.82bn | 309.60m | 14.14bn | 14.50k | 45.73 | 2.55 | 19.79 | 2.07 | 0.4544 | 0.4544 | 10.01 | 8.16 | 0.532 | 5.56 | 6.09 | 470,331.00 | 2.42 | 2.97 | 2.75 | 3.35 | 33.53 | 33.44 | 4.54 | 5.06 | 1.06 | 3.29 | 0.4698 | 0.00 | -7.26 | 3.51 | -51.52 | -- | 31.17 | -- |
| Align Technology, Inc. | 3.96bn | 441.57m | 16.86bn | 21.61k | 38.50 | 4.28 | 28.96 | 4.26 | 5.87 | 5.87 | 52.63 | 52.76 | 0.6245 | 4.32 | 4.14 | 183,272.50 | 6.96 | 16.34 | 10.39 | 24.14 | 69.98 | 71.72 | 11.15 | 23.16 | 1.14 | -- | 0.00 | 0.00 | 3.42 | 14.45 | 23.09 | 2.15 | -4.46 | -- |
| Baxter International Inc | 11.77bn | 225.00m | 16.94bn | 60.00k | 75.13 | 2.15 | 12.92 | 1.44 | 0.442 | 0.214 | 23.10 | 15.42 | 0.4105 | 2.91 | 5.42 | 196,133.30 | 0.8198 | 0.1942 | 1.05 | 0.2333 | 38.43 | 38.20 | 2.00 | 0.3674 | 1.09 | 3.81 | 0.6196 | 1,398.94 | 2.12 | 5.94 | 97.15 | -- | 0.982 | 9.71 |
| Hologic Inc | 4.03bn | 789.50m | 18.34bn | 6.99k | 23.78 | 3.58 | 16.70 | 4.55 | 3.32 | 3.32 | 16.97 | 22.09 | 0.4406 | 2.72 | 6.57 | -- | 8.63 | 13.12 | 9.84 | 15.20 | 56.25 | 60.82 | 19.59 | 24.75 | 3.03 | 64.45 | 0.3307 | -- | -0.0025 | 3.66 | 73.14 | -- | 4.30 | -- |
| Insulet Corp | 1.98bn | 420.90m | 18.44bn | 3.00k | 45.71 | 16.50 | 36.96 | 9.30 | 5.75 | 5.75 | 25.96 | 15.94 | 0.7223 | 1.42 | 6.14 | 661,300.00 | 15.32 | 2.71 | 18.56 | 3.14 | 69.36 | 65.81 | 21.22 | 4.28 | 2.80 | 98.71 | 0.5557 | 0.00 | 30.02 | 24.66 | 4,384.78 | 128.77 | -7.63 | -- |
| Cooper Companies Inc | 3.80bn | 359.30m | 20.07bn | 15.00k | 56.13 | 2.53 | 27.27 | 5.28 | 1.80 | 1.80 | 19.02 | 39.80 | 0.3196 | 1.70 | 5.56 | 253,606.70 | 3.02 | 10.06 | 3.29 | 11.34 | 66.36 | 65.54 | 9.45 | 29.00 | 1.18 | 5.46 | 0.2493 | 0.3469 | 8.61 | 7.24 | -23.74 | -3.66 | 15.18 | 0.00 |
| Steris PLC | 5.12bn | 602.62m | 21.16bn | 18.18k | 35.28 | 3.21 | 19.10 | 4.13 | 6.08 | 4.38 | 51.62 | 66.80 | 0.4758 | 3.86 | 5.49 | 281,655.40 | 5.62 | 5.19 | 6.10 | 5.68 | 43.01 | 43.64 | 11.81 | 10.97 | 1.55 | 8.29 | 0.2528 | 36.56 | 13.28 | 13.06 | -1.07 | 12.67 | 13.69 | 8.83 |
| Zimmer Biomet Holdings Inc | 7.60bn | 1.08bn | 21.94bn | 18.00k | 20.99 | 1.78 | 10.66 | 2.89 | 5.25 | 5.25 | 36.87 | 62.00 | 0.3538 | 0.9136 | 5.38 | 421,972.20 | 5.05 | 2.21 | 5.82 | 2.52 | 71.78 | 71.25 | 14.28 | 7.28 | 0.6987 | 7.52 | 0.3425 | 38.90 | 6.55 | -1.40 | 252.86 | -- | 9.44 | 0.00 |
| Waters Corp | 2.91bn | 622.64m | 22.18bn | 7.90k | 35.63 | 13.83 | 27.22 | 7.63 | 10.48 | 10.48 | 48.89 | 27.00 | 0.645 | 2.20 | 4.47 | 367,740.10 | 13.82 | 19.77 | 16.72 | 25.29 | 59.73 | 58.45 | 21.43 | 23.38 | 1.38 | 10.11 | 0.5325 | 0.00 | -0.5229 | 4.09 | -9.26 | 1.53 | 4.72 | -- |
| Illumina Inc | 4.39bn | -1.58bn | 22.23bn | 10.59k | -- | 10.49 | -- | 5.06 | -10.00 | -10.00 | 27.61 | 13.36 | 0.5441 | 2.66 | 6.17 | 414,542.00 | -19.63 | -6.20 | -23.16 | -7.28 | 63.94 | 66.39 | -36.08 | -15.48 | 1.85 | 38.44 | 0.4834 | -- | -1.75 | 6.21 | 73.64 | -- | -7.91 | -- |
| West Pharmaceutical Services Inc. | 2.88bn | 499.60m | 22.93bn | 10.60k | 46.91 | 8.34 | 36.15 | 7.97 | 6.75 | 6.75 | 38.86 | 37.96 | 0.7743 | 4.50 | 5.51 | 271,358.50 | 13.02 | 15.61 | 15.16 | 18.65 | 34.87 | 38.06 | 16.81 | 18.47 | 2.23 | -- | 0.0695 | 10.69 | 2.18 | 11.43 | 2.28 | 23.76 | 28.16 | 6.20 |
| DexCom Inc | 3.95bn | 680.80m | 28.45bn | 9.60k | 44.46 | 14.37 | 31.85 | 7.19 | 1.64 | 1.64 | 9.52 | 5.07 | 0.6107 | 2.76 | 4.42 | 411,875.00 | 10.51 | 8.30 | 14.28 | 10.50 | 62.10 | 65.90 | 17.22 | 14.14 | 2.12 | -- | 0.5579 | 0.00 | 24.49 | 28.56 | 58.70 | -- | 28.66 | -- |
Data as of Nov 23 2024. Currency figures normalised to Waters Corp's reporting currency: US Dollar USD
47.88%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 30 Sep 2024 | 6.81m | 11.47% |
| Fundsmith LLPas of 30 Sep 2024 | 4.87m | 8.21% |
| BlackRock Fund Advisorsas of 30 Sep 2024 | 3.87m | 6.51% |
| SSgA Funds Management, Inc.as of 30 Sep 2024 | 2.58m | 4.34% |
| AllianceBernstein LPas of 30 Sep 2024 | 2.44m | 4.11% |
| Massachusetts Financial Services Co.as of 30 Sep 2024 | 2.14m | 3.60% |
| Generation Investment Management LLPas of 30 Sep 2024 | 1.81m | 3.04% |
| Walter Scott & Partners Ltd.as of 30 Sep 2024 | 1.57m | 2.65% |
| Geode Capital Management LLCas of 30 Sep 2024 | 1.42m | 2.39% |
| GuardCap Asset Management Ltd.as of 30 Sep 2024 | 917.53k | 1.55% |
More ▼
Data from 30 Sep 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
